Baltimore News Journal – Lifestyle
Author:
ALTERITY THERAPEUTICS LIMITED
Alterity Therapeutics Announces Late-Breaker Oral Presentation at the American Academy of Neurology Annual Meeting
April 16, 2026
Alterity Therapeutics to Host Virtual KOL Event to Share New Insights on ATH434 for the Treatment of Multiple System Atrophy
April 15, 2026
Alterity Therapeutics Receives Positive FDA Feedback Following Type C Meeting on ATH434 Phase 3 Program
March 30, 2026
Alterity Therapeutics to Participate in the Bell Potter Healthcare Horizons Summit
March 26, 2026